TY  - JOUR 
AU  - Triviño Ibáñez, Eva María
AU  - Sánchez-Vañó, Raquel
AU  - Sopena Novales, Pablo
AU  - Romero Fábrega, Juan Carlos
AU  - Rodríguez Fernández, Antonio
AU  - Carnero Pardo, Cristóbal
AU  - Martínez Lozano, María Dolores
AU  - Gómez Río, Manuel
PY  - 2019
UR  - http://hdl.handle.net/10481/62085
AB  - To evaluate the use of amyloid-positron emission tomography (PET) in routine clinical practice, in a selected population with cognitive
impairment that meets appropriate use criteria (AUC).
A multicenter, observational, prospective case-series study...
LA  - eng
PB  - Wolters Kluwer Health, Inc
KW  - Alzheimer’s disease
KW  - Appropriate use criteria
KW  - Amyloid PET
KW  - Mild cognitive impairment
KW  - Florbetaben PET
TI  - Impact of amyloid-PET in daily clinical management of patients with cognitive impairment fulfilling appropriate use criteria
DO  - 10.1097/MD.0000000000016509
ER  -